Healthcare

Biotechnology firm VolitionRX Ltd. enters a critical period marked by two significant corporate developments: the release of fresh clinical study...

ImmunityBio has entered 2026 with significant momentum, propelled by a confluence of fresh clinical data, key regulatory communications, and international...

CVS Health is confronting significant margin pressure after U.S. health program administrators announced a reimbursement rate adjustment that fell dramatically...

A period of aggressive acquisitions and strategic refocusing defined 2025 for Healwell AI, dramatically reshaping its financial profile. However, the...

Investor attention has returned to BioNxt Solutions following the release of encouraging new laboratory data. The company's latest preclinical study...

The healthcare behemoth UnitedHealth is embarking on a significant strategic shift, prioritizing long-term stability over immediate profits. In a move...

BioNxt Solutions Inc. has announced a key preclinical milestone for its experimental multiple sclerosis therapy. The Canadian biotechnology firm’s innovative...

Shares of Altria Group, Inc. have continued their upward trajectory, building on gains seen over recent months. This positive momentum...

Shares of Viking Therapeutics experienced a significant rally in today's trading session, marking a notable recovery after a volatile period...

A stark divergence has emerged for Healwell AI, a Canadian artificial intelligence specialist. While the company's latest financial results point...